nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—lung cancer	0.385	1	CbGaD
Flupentixol—ABCB1—Topotecan—lung cancer	0.0615	0.136	CbGbCtD
Flupentixol—ABCB1—Gefitinib—lung cancer	0.0563	0.124	CbGbCtD
Flupentixol—ABCB1—Vinorelbine—lung cancer	0.0434	0.0958	CbGbCtD
Flupentixol—ABCB1—Crizotinib—lung cancer	0.0345	0.0762	CbGbCtD
Flupentixol—ABCB1—Gemcitabine—lung cancer	0.0337	0.0745	CbGbCtD
Flupentixol—ABCB1—Erlotinib—lung cancer	0.0333	0.0735	CbGbCtD
Flupentixol—ABCB1—Paclitaxel—lung cancer	0.0305	0.0673	CbGbCtD
Flupentixol—ABCB1—Irinotecan—lung cancer	0.0301	0.0664	CbGbCtD
Flupentixol—ABCB1—Vinblastine—lung cancer	0.0267	0.059	CbGbCtD
Flupentixol—ABCB1—Cisplatin—lung cancer	0.0245	0.0541	CbGbCtD
Flupentixol—ABCB1—Etoposide—lung cancer	0.0241	0.0532	CbGbCtD
Flupentixol—ABCB1—Docetaxel—lung cancer	0.022	0.0486	CbGbCtD
Flupentixol—HTR2A—phrenic nerve—lung cancer	0.0172	0.402	CbGeAlD
Flupentixol—ABCB1—Doxorubicin—lung cancer	0.0164	0.0363	CbGbCtD
Flupentixol—ABCB1—Methotrexate—lung cancer	0.0159	0.0351	CbGbCtD
Flupentixol—HTR2A—pulmonary artery—lung cancer	0.00625	0.146	CbGeAlD
Flupentixol—DDC—respiratory system—lung cancer	0.00367	0.0858	CbGeAlD
Flupentixol—DDC—lung—lung cancer	0.00195	0.0456	CbGeAlD
Flupentixol—DRD2—respiratory system—lung cancer	0.00159	0.0373	CbGeAlD
Flupentixol—CHRM1—trachea—lung cancer	0.00146	0.0342	CbGeAlD
Flupentixol—ADRA1A—epithelium—lung cancer	0.00136	0.0318	CbGeAlD
Flupentixol—DDC—lymph node—lung cancer	0.00133	0.0312	CbGeAlD
Flupentixol—HTR2A—respiratory system—lung cancer	0.00105	0.0246	CbGeAlD
Flupentixol—CHRM1—lung—lung cancer	0.00105	0.0246	CbGeAlD
Flupentixol—HTR2A—epithelium—lung cancer	0.000878	0.0205	CbGeAlD
Flupentixol—DRD2—lung—lung cancer	0.000846	0.0198	CbGeAlD
Flupentixol—HTR2A—trachea—lung cancer	0.000776	0.0182	CbGeAlD
Flupentixol—ABCB1—respiratory system—lung cancer	0.000688	0.0161	CbGeAlD
Flupentixol—ABCB1—epithelium—lung cancer	0.000575	0.0135	CbGeAlD
Flupentixol—HTR2A—lung—lung cancer	0.000558	0.013	CbGeAlD
Flupentixol—ABCB1—trachea—lung cancer	0.000509	0.0119	CbGeAlD
Flupentixol—ABCB1—bone marrow—lung cancer	0.000403	0.00944	CbGeAlD
Flupentixol—ABCB1—lung—lung cancer	0.000366	0.00855	CbGeAlD
Flupentixol—ABCB1—lymph node—lung cancer	0.00025	0.00585	CbGeAlD
Flupentixol—Fluphenazine—CYP2E1—lung cancer	0.000119	0.335	CrCbGaD
Flupentixol—Thiothixene—ALB—lung cancer	7.57e-05	0.213	CrCbGaD
Flupentixol—Fluphenazine—ABCB1—lung cancer	6.24e-05	0.176	CrCbGaD
Flupentixol—Trifluoperazine—ABCB1—lung cancer	4.99e-05	0.14	CrCbGaD
Flupentixol—Quetiapine—ABCB1—lung cancer	4.84e-05	0.136	CrCbGaD
Flupentixol—HTR2A—Signaling Pathways—HIF1A—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HIF1A—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—FGFR1—lung cancer	1.39e-05	0.000117	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—APOA1—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HIF1A—lung cancer	1.37e-05	0.000115	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KDR—lung cancer	1.36e-05	0.000114	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GSTP1—lung cancer	1.35e-05	0.000114	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—APOA1—lung cancer	1.35e-05	0.000113	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—APOA1—lung cancer	1.34e-05	0.000113	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KDR—lung cancer	1.33e-05	0.000112	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KDR—lung cancer	1.33e-05	0.000112	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CAT—lung cancer	1.32e-05	0.000111	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—APOA1—lung cancer	1.32e-05	0.000111	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—PIK3CA—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KDR—lung cancer	1.31e-05	0.00011	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MDM2—lung cancer	1.3e-05	0.00011	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RAF1—lung cancer	1.3e-05	0.000109	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ERBB2—lung cancer	1.28e-05	0.000108	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CB—lung cancer	1.27e-05	0.000107	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MTOR—lung cancer	1.27e-05	0.000107	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TYMS—lung cancer	1.26e-05	0.000106	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CG—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KIT—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—APC—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—NRAS—lung cancer	1.25e-05	0.000105	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GSTM1—lung cancer	1.24e-05	0.000105	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGF—lung cancer	1.23e-05	0.000104	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KIT—lung cancer	1.23e-05	0.000103	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CG—lung cancer	1.23e-05	0.000103	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—APC—lung cancer	1.23e-05	0.000103	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—NRAS—lung cancer	1.23e-05	0.000103	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CG—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KIT—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—APC—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—NRAS—lung cancer	1.22e-05	0.000103	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCL8—lung cancer	1.22e-05	0.000102	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGF—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—HRAS—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGF—lung cancer	1.21e-05	0.000102	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—APC—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KIT—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—NRAS—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—MAPK3—lung cancer	1.2e-05	0.000101	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGF—lung cancer	1.19e-05	0.0001	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—POMC—lung cancer	1.19e-05	9.99e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CYP1A1—lung cancer	1.18e-05	9.92e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—MAPK3—lung cancer	1.18e-05	9.89e-05	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AKT1—lung cancer	1.18e-05	9.89e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—BRAF—lung cancer	1.17e-05	9.87e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ERCC2—lung cancer	1.17e-05	9.84e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—MAPK3—lung cancer	1.17e-05	9.84e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—POMC—lung cancer	1.17e-05	9.83e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CASP3—lung cancer	1.17e-05	9.8e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL2—lung cancer	1.16e-05	9.79e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—POMC—lung cancer	1.16e-05	9.78e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6R—lung cancer	1.16e-05	9.75e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—IL6—lung cancer	1.16e-05	9.74e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CREBBP—lung cancer	1.16e-05	9.73e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—BRAF—lung cancer	1.15e-05	9.71e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	1.15e-05	9.69e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—BRAF—lung cancer	1.15e-05	9.66e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—POMC—lung cancer	1.15e-05	9.63e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6R—lung cancer	1.14e-05	9.59e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CREBBP—lung cancer	1.14e-05	9.58e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—lung cancer	1.14e-05	9.57e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6R—lung cancer	1.13e-05	9.54e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CCND1—lung cancer	1.13e-05	9.54e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CREBBP—lung cancer	1.13e-05	9.53e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—JUN—lung cancer	1.13e-05	9.52e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—BRAF—lung cancer	1.13e-05	9.51e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—lung cancer	1.12e-05	9.41e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6R—lung cancer	1.12e-05	9.39e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CREBBP—lung cancer	1.12e-05	9.38e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—lung cancer	1.11e-05	9.36e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAP2K1—lung cancer	1.11e-05	9.29e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MMP9—lung cancer	1.1e-05	9.26e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CD—lung cancer	1.1e-05	9.23e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CDKN1A—lung cancer	1.1e-05	9.23e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—lung cancer	1.1e-05	9.22e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PTEN—lung cancer	1.1e-05	9.21e-05	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	1.09e-05	9.14e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAP2K1—lung cancer	1.09e-05	9.14e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.08e-05	9.09e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CD—lung cancer	1.08e-05	9.08e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—KRAS—lung cancer	1.07e-05	9.04e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.07e-05	9.03e-05	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—PIK3CA—lung cancer	1.07e-05	9e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AKT1—lung cancer	1.07e-05	8.98e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	1.06e-05	8.95e-05	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.06e-05	8.95e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	1.06e-05	8.89e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—KRAS—lung cancer	1.06e-05	8.89e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.05e-05	8.84e-05	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	1.05e-05	8.81e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EP300—lung cancer	1.04e-05	8.78e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—KRAS—lung cancer	1.04e-05	8.71e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—SRC—lung cancer	1.02e-05	8.54e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—APOA1—lung cancer	1.01e-05	8.51e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—VEGFA—lung cancer	9.89e-06	8.32e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—PIK3CA—lung cancer	9.87e-06	8.3e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MDM2—lung cancer	9.83e-06	8.27e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RAF1—lung cancer	9.8e-06	8.24e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—STAT3—lung cancer	9.79e-06	8.24e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—NRAS—lung cancer	9.77e-06	8.21e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—PIK3CA—lung cancer	9.72e-06	8.17e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ERBB2—lung cancer	9.7e-06	8.15e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MDM2—lung cancer	9.68e-06	8.14e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	9.66e-06	8.13e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RAF1—lung cancer	9.64e-06	8.11e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MDM2—lung cancer	9.62e-06	8.09e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RAF1—lung cancer	9.59e-06	8.06e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CB—lung cancer	9.57e-06	8.05e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MTOR—lung cancer	9.57e-06	8.05e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ERBB2—lung cancer	9.54e-06	8.02e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	9.51e-06	8e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ERBB2—lung cancer	9.49e-06	7.98e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MDM2—lung cancer	9.47e-06	7.97e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RAF1—lung cancer	9.44e-06	7.94e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MTOR—lung cancer	9.41e-06	7.92e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CB—lung cancer	9.41e-06	7.92e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CB—lung cancer	9.36e-06	7.87e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MTOR—lung cancer	9.36e-06	7.87e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MAPK3—lung cancer	9.36e-06	7.87e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ERBB2—lung cancer	9.34e-06	7.85e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CG—lung cancer	9.24e-06	7.77e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MTOR—lung cancer	9.22e-06	7.75e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	9.22e-06	7.75e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCL8—lung cancer	9.19e-06	7.73e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—HRAS—lung cancer	9.14e-06	7.68e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—MYC—lung cancer	9.1e-06	7.65e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCL8—lung cancer	9.05e-06	7.61e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCL8—lung cancer	9e-06	7.57e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—HRAS—lung cancer	8.99e-06	7.56e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—HRAS—lung cancer	8.94e-06	7.52e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—lung cancer	8.9e-06	7.48e-05	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AKT1—lung cancer	8.88e-06	7.47e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCL8—lung cancer	8.86e-06	7.45e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—HRAS—lung cancer	8.8e-06	7.4e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CASP3—lung cancer	8.8e-06	7.4e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—POMC—lung cancer	8.8e-06	7.4e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL2—lung cancer	8.79e-06	7.39e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—IL6—lung cancer	8.74e-06	7.35e-05	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AKT1—lung cancer	8.74e-06	7.35e-05	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AKT1—lung cancer	8.69e-06	7.31e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CASP3—lung cancer	8.66e-06	7.28e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL2—lung cancer	8.65e-06	7.27e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CASP3—lung cancer	8.61e-06	7.24e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—IL6—lung cancer	8.6e-06	7.23e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL2—lung cancer	8.6e-06	7.23e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CREBBP—lung cancer	8.57e-06	7.21e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CCND1—lung cancer	8.57e-06	7.2e-05	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	8.56e-06	7.2e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—IL6—lung cancer	8.56e-06	7.19e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—JUN—lung cancer	8.55e-06	7.19e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CASP3—lung cancer	8.48e-06	7.13e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL2—lung cancer	8.47e-06	7.12e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CCND1—lung cancer	8.43e-06	7.09e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—IL6—lung cancer	8.42e-06	7.08e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—JUN—lung cancer	8.41e-06	7.07e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—KRAS—lung cancer	8.41e-06	7.07e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CCND1—lung cancer	8.38e-06	7.05e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—JUN—lung cancer	8.37e-06	7.03e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MMP9—lung cancer	8.32e-06	6.99e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CDKN1A—lung cancer	8.29e-06	6.97e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PTEN—lung cancer	8.27e-06	6.95e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CCND1—lung cancer	8.25e-06	6.94e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—JUN—lung cancer	8.24e-06	6.92e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MMP9—lung cancer	8.18e-06	6.88e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CDKN1A—lung cancer	8.15e-06	6.86e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MMP9—lung cancer	8.14e-06	6.84e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PTEN—lung cancer	8.14e-06	6.84e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CD—lung cancer	8.13e-06	6.83e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CDKN1A—lung cancer	8.11e-06	6.82e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PTEN—lung cancer	8.09e-06	6.8e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AKT1—lung cancer	8.07e-06	6.78e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ALB—lung cancer	8.02e-06	6.75e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MMP9—lung cancer	8.01e-06	6.74e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	7.98e-06	6.71e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PTEN—lung cancer	7.97e-06	6.7e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AKT1—lung cancer	7.94e-06	6.67e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AKT1—lung cancer	7.89e-06	6.64e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EP300—lung cancer	7.89e-06	6.63e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AKT1—lung cancer	7.77e-06	6.53e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EP300—lung cancer	7.76e-06	6.52e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PIK3CA—lung cancer	7.73e-06	6.5e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EP300—lung cancer	7.72e-06	6.49e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—SRC—lung cancer	7.67e-06	6.45e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EP300—lung cancer	7.6e-06	6.39e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—SRC—lung cancer	7.54e-06	6.34e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—SRC—lung cancer	7.5e-06	6.31e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—TP53—lung cancer	7.47e-06	6.28e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—VEGFA—lung cancer	7.47e-06	6.28e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—STAT3—lung cancer	7.39e-06	6.22e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—SRC—lung cancer	7.39e-06	6.21e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—NRAS—lung cancer	7.38e-06	6.2e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—VEGFA—lung cancer	7.35e-06	6.18e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—VEGFA—lung cancer	7.31e-06	6.15e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—STAT3—lung cancer	7.28e-06	6.12e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—NRAS—lung cancer	7.26e-06	6.1e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—STAT3—lung cancer	7.24e-06	6.08e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—NRAS—lung cancer	7.22e-06	6.07e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—VEGFA—lung cancer	7.2e-06	6.05e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—HRAS—lung cancer	7.15e-06	6.01e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—STAT3—lung cancer	7.12e-06	5.99e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—NRAS—lung cancer	7.11e-06	5.98e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CB—lung cancer	7.08e-06	5.96e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MAPK3—lung cancer	7.06e-06	5.94e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTGS2—lung cancer	7.02e-06	5.9e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MAPK3—lung cancer	6.95e-06	5.84e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MAPK3—lung cancer	6.91e-06	5.81e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—MYC—lung cancer	6.87e-06	5.78e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—IL6—lung cancer	6.84e-06	5.75e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MAPK3—lung cancer	6.81e-06	5.72e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—MYC—lung cancer	6.76e-06	5.68e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—MYC—lung cancer	6.72e-06	5.65e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—lung cancer	6.72e-06	5.65e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—MYC—lung cancer	6.62e-06	5.57e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—lung cancer	6.61e-06	5.56e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—lung cancer	6.58e-06	5.53e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—lung cancer	6.47e-06	5.44e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—KRAS—lung cancer	6.35e-06	5.34e-05	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AKT1—lung cancer	6.31e-06	5.31e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—KRAS—lung cancer	6.25e-06	5.25e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—KRAS—lung cancer	6.21e-06	5.22e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PTEN—lung cancer	6.12e-06	5.15e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—KRAS—lung cancer	6.12e-06	5.14e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—EP300—lung cancer	5.84e-06	4.91e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PIK3CA—lung cancer	5.83e-06	4.9e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PIK3CA—lung cancer	5.74e-06	4.83e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PIK3CA—lung cancer	5.71e-06	4.8e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—TP53—lung cancer	5.64e-06	4.74e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	5.62e-06	4.73e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—TP53—lung cancer	5.55e-06	4.67e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—TP53—lung cancer	5.52e-06	4.64e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—TP53—lung cancer	5.44e-06	4.57e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—HRAS—lung cancer	5.4e-06	4.54e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—HRAS—lung cancer	5.31e-06	4.46e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—HRAS—lung cancer	5.28e-06	4.44e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—HRAS—lung cancer	5.2e-06	4.37e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—IL6—lung cancer	5.17e-06	4.34e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—IL6—lung cancer	5.08e-06	4.27e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—IL6—lung cancer	5.05e-06	4.25e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—IL6—lung cancer	4.98e-06	4.18e-05	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AKT1—lung cancer	4.76e-06	4.01e-05	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AKT1—lung cancer	4.69e-06	3.94e-05	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AKT1—lung cancer	4.66e-06	3.92e-05	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AKT1—lung cancer	4.59e-06	3.86e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—PIK3CA—lung cancer	4.32e-06	3.63e-05	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AKT1—lung cancer	3.53e-06	2.97e-05	CbGpPWpGaD
